Page last updated: 2024-12-07

3-methyl-s-triazolo(3,4-a)phthalazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-methyl-s-triazolo(3,4-a)phthalazine: metabolite of hydralazine; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3-methyl-1,2,4-triazolo[3,4-a]phthalazine : A 1,2,4-triazolo[3,4-a]phthalazine having a methyl substituent at the 3-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID97339
CHEBI ID60480
MeSH IDM0052414

Synonyms (25)

Synonym
1,4-triazolo[3,4-a]phthalazine, 3-methyl-
s-triazolo[3, 3-methyl-
nsc116346
nsc-116346
20062-41-3
3-methyltriazolophthalazine
3-methyl-1,2,4-triazolo[3,4-a]phthalazine
CHEBI:60480 ,
3-methyl-s-triazolo[3,4-a]phthalazine
3-methyl[1,2,4]triazolo[3,4-a]phthalazine
3-methyl-[1,2,4]triazolo[3,4-a]phthalazine
AKOS006271459
nsc 116346
03760vrh6p ,
unii-03760vrh6p
s-triazolo(3,4-a)phthalazine, 3-methyl-
3-methyl-s-triazolo(3,4-a)phthalazine
1,2,4-triazolo(3,4-a)phthalazine, 3-methyl-
FT-0672245
EPITOPE ID:137350
3-methyltriazolo(3,4-a)phthalazine
DTXSID90173878
1,2,4-triazolo[3,4-a]phthalazine, 3-methyl-
J-012987
Q27127311

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" All the hydrazones studied had an effective hypotensive effect after a high dosing (10 mg/kg); however, their potency was much smaller than that of HP, when plasma-free concentration-response curves were compared."( Pharmacokinetics of formation and excretion of some metabolites of hydralazine and their hypotensive effect in rats.
Iwaki, M; Ogiso, T; Ohtsuki, N, 1985
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
triazolophthalazineAn organic heterotricyclic compound comprising a triazole ring fused to a phthalazine ring system.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.23 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]